Organization: Health Canada
Year: 2023
Month: January
Request Number: A-2022-000707
Request Summary: Adverse Drug Reactions (ADRs) for MEZAVANT. Report numbers: E2B_05453742, E2B_05453440, E2B_05468870, 999191. ADRs for Mesalazine. Report numbers: E2B_05436585, E2B_05477862, E2B_05437946, E2B_05469245, E2B_05479746, E2B_05463054.
Disposition: Disclosed in part
Number of pages: 227